BioAffinity Technologies Inc Stock, NASDAQ:BIAF
22211 West Interstate 10, Suite 1206, San Antonio, Texas 78257
United States of America
Number of Employees: 14
bioAffinity Technologies, Inc. operates as a development-stage company addressing the significant unmet need for non-invasive, early-stage cancer diagnosis and treatment. The firm develops proprietary in-vitro diagnostic tests and targeted cancer therapeutics using breakthrough technology that preferentially targets cancer cells. The company was founded on March 26, 2014 and is headquartered in San Antonio, TX.